Third Party Tablet Manufacturing in India

WHO-GMP certified plant at Dabkori, Panchkula

Vibcare Healthcare provides third party tablet manufacturing from its own plant in Panchkula, Haryana, for general tablets. Granulation, compression, coating, blister and strip packing all sit in one block, with an installed capacity of 1.1 billion tablets a year. Foil for blister and strip packs is printed inside the plant on our own rotogravure unit, which keeps artwork changes and repeat orders on our schedule rather than a converter’s.

Third party tablet manufacturing, by the numbers

Installed capacity, approvals and the plant behind them

1.1 Billiontablets a year installed capacity
334tablet formulations on our product list
750+total product approvals, all dosage forms
Since 2023plant commissioned at Dabkori

Inside the tablet section

The machines your batch actually runs on

The section runs as one line from dispensing to secondary packing. Two granulation lines feed the compression room, coated batches move to the coater in the same block, and packing follows on blister, alu-alu and strip machines.

Granulation
Two lines from Saral Pharma Machines, with rapid mixer granulator, dryer and multi-mill
Compression
27-station and 37-station rotary presses from Karnavati Engineering
Coating
48-inch auto-coater from Gansons, for film and enteric coating
Tablet types
Uncoated, film-coated, enteric-coated, sustained and prolonged-release, dispersible and bilayer tablets. 56 modified-release and 7 dispersible tablets are already on the product list.
Blister and alu-alu
Packing machines from Elmach Packages and Rapid-Pack Engineering
Strip packing
Machines from Satellite Engineers
Foil printing
4-colour rotogravure from Mohindra Mechanical Works, running inside the plant

Packing formats and change parts

What we are already tooled for

The pack is set by the change part — the tooling that fixes pocket shape, tablet count and strip size. A format already tooled runs without new tooling cost or added lead time. Some of what is currently in use:

Six-tablet blister with large round pockets6 tabletsLarge round pocket, clear base
Ten-tablet blister with oblong pockets10 tabletsOblong pocket, clear base
Fifteen-tablet blister with oblong pockets15 tabletsOblong pocket, 5 x 3
Thirty-tablet blister with small round pockets on an opaque base30 tabletsSmall round pocket, opaque base
Ten-tablet blister on a printed coloured base10 tabletsPrinted coloured base
Combination kit blister with mixed pockets and a printed dosing panelCombination kitMixed pockets, printed dosing panel

Blister runs in PVC and PVDC, alu-alu for moisture-sensitive products, and aluminium strip. Bottles are available in HDPE, PET and glass. Secondary packing covers mono cartons, unit packs and shippers.

Approvals for the tablet section

All issued to Vibcare Healthcare Pvt Ltd for the Dabkori site

WHO-GMP site certificate
No. 1/182-1Drug-I-2024/10117, issued 24 October 2024 by the State Drugs Controller-cum-Licensing Authority, Food and Drugs Administration, Haryana. Covers general tablets for production, packing and quality control.
GMP — Revised Schedule M
Memo No. 1/182-1Drug-1-2024, dated 14 November 2024, Office of the State Drugs Controller, FDA Haryana
GLP certificate
No. 1/182-1Drug-I-2024/10589, for the quality control and microbiology laboratories
Manufacturing licence
Form 25: MLF252023HR000004, under the Drugs and Cosmetics Act, 1940, valid to 7 May 2028
Quality management
ISO 9001:2015, certificate US-VTRM-25-25255390, issued 25 March 2025

Tablets already on the licence

334 tablet formulations across 34 therapeutic segments

Total approvals across all dosage forms run past 750. Of the tablets on our published product list, these are the ten largest segments. A product already on the list can be quoted against a batch size straight away; anything new needs a product permission from FDA Haryana, which we apply for and give you a timeline on.

Anti-diabetic
59
Cardiovascular
57
NSAIDs, analgesic and anti-pyretic
44
Anti-cold and anti-allergic
19
Antibiotics
17
Anxiolytic, anti-convulsant and anti-psychotic
14
Anti-asthmatic and bronchodilator
11
Anti-fungal, anti-helmintic and anti-viral
11
Diuretic
10
Anti-oxidant and vitamins
9
24 further segments — neuropathic pain, PPIs, anti-spasmodic, bladder and prostate, anticoagulants, DMARDs, antimigraine, antivertigo, corticosteroids and others
83

Quality control and release

GLP certified laboratories in a separate block

Chemical and instrumental

HPLC from Shimadzu, dissolution apparatus from Electrolab, UV spectrophotometry and precision balances, with supporting instruments from LabIndia and PCI Analytics. Full pharmacopoeial testing of raw material and finished product.

Microbiology

A separate microbiology laboratory with HEPA-filtered laminar air flow units, running microbial limit testing, water testing and environmental monitoring of the classified areas.

Stability

Stability chambers from Thermolab running ICH accelerated and long-term studies, with trending and shelf-life data held as records.

With every batch

Batch manufacturing record, in-process check data and a certificate of analysis released against written specifications before dispatch.

The plant

Purpose-built at Dabkori, Panchkula

Manufacturing block at the Vibcare Healthcare plant, Dabkori, Panchkula

Two blocks, one direction of flow

Material and personnel flows are kept in one direction across the site.

Block 1 holds manufacturing and packing for tablets, capsules, oral liquids and external preparations, with finished goods storage and dispatch.

Block 2 holds quality control, microbiology, quality assurance, the raw and packing material warehouses, and administration.

The site is licensed for the general section. Beta-lactam products are not made here, so no segregation between beta-lactam and general campaigns is required.

More about the plant

HVAC
57 air handling units from Edgetech serving production and QC, with chillers from Blue Star
Purified water
RO system with SS 316L storage and a continuously circulating distribution loop
Power
Diesel generator backup, 380 kVA and 62.5 kVA
Process utilities
Steam generation and compressed air
Building management
BMS built on ABB, Honeywell and Siemens hardware
Environment and safety
Effluent and sewage treatment plant, fire hydrant and fire safety systems across the site

Support beyond the batch

What comes with the manufacturing

Technology transfer

Transfer from your R&D or pilot scale onto our equipment, with critical process parameters and in-process controls agreed before the first commercial batch.

Analytical

Method transfer, verification and validation carried out in our own laboratories.

Registration

Stability data and documentation for product registration and for export dossiers.

Tablets for export

34 tablet approvals written to USP and BP monographs

39 export approvals sit on the licence, 34 of them tablets — amlodipine, atorvastatin, azithromycin, bisoprolol, carvedilol, esomeprazole, levetiracetam, levofloxacin, linezolid, losartan, metformin prolonged-release, moxifloxacin, pantoprazole, propranolol, rosuvastatin and telmisartan among them.

Markets supplied: Myanmar, Ethiopia, Nigeria, Kenya, Tanzania, Uzbekistan, Nepal, Afghanistan, Yemen, Zimbabwe, Mali, Tajikistan, Burkina Faso, Uganda, Zambia, Philippines, Côte d’Ivoire, El Salvador, Benin, Bhutan, Cameroon and Ghana.

How to start

Five steps from brief to dispatch

  1. Send the brief. Composition, strength, pack size, annual quantity and the market.
  2. Feasibility. We check the formulation against the licence and the pack against the change parts we hold.
  3. Quotation. Rate, batch size, lead time, payment terms, and any change part cost, in writing.
  4. Artwork and permission. Artwork checked against labelling requirements; product permission applied for where the formulation is new to the licence.
  5. Manufacture and release. Batch record and certificate of analysis travel with the consignment.

Questions buyers ask

Before you send a brief

Is the tablet section WHO-GMP certified?

Yes. WHO-GMP site certificate No. 1/182-1Drug-I-2024/10117, issued by the State Drugs Controller, FDA Haryana on 24 October 2024. General tablets are named on it for production, packing and quality control.

Do you manufacture beta-lactam tablets?

No. The site is licensed for the general section only.

What is the annual tablet capacity?

1.1 billion tablets a year. The same plant runs 950 million capsules, 30 million bottles of oral liquid and 40 million tubes of external preparations a year, so a range spanning more than one dosage form can be made at one site.

Which pack formats can you supply?

PVC and PVDC blister, alu-alu, aluminium strip, and HDPE, PET or glass bottles, finished into mono cartons and shippers. Blister and strip foil is printed on the 4-colour rotogravure unit inside the plant.

What if the format I want is not tooled yet?

A new format needs a new change part. We quote the tooling cost and the time it adds along with the rate, before the order is placed.

Can you make a product that is not on the approved list?

Yes, for tablets within the licensed scope. It needs a product permission from the Food and Drugs Administration, Haryana. We apply for it and give you the expected timeline with the quotation.

What is the minimum order quantity?

It follows the batch size, which depends on the composition and the granulation route. The minimum batch quantity for your product comes with the quotation, along with the rate at that quantity.

Do you supply for export?

Yes. 39 export approvals to USP and BP monographs, 34 of them tablets, currently supplying 22 markets across Asia, Africa and Latin America. Stability data and registration documentation are prepared in our own laboratories.

Talk to us about your tablet range

Send the composition, pack size and annual quantity. You will get feasibility, rate, batch size and lead time in writing.

info.vh@vibcare.co.in  ·  +91 85660 76607  ·  Khasra 6/2/2, Kot Road, Village Dabkori, Panchkula, Haryana 134103